Literature DB >> 1763186

Leukotriene antagonists and inhibitors of leukotriene biosynthesis as potential therapeutic agents.

J A Salmon1, L G Garland.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1763186     DOI: 10.1007/978-3-0348-7139-6_1

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN: 0071-786X


× No keyword cloud information.
  6 in total

1.  The pharmacokinetics and metabolism of SC-53228, a specific leukotriene B4 receptor antagonist.

Authors:  S Paulson; Y Readus; S Bulik; G Schoenhard; J Stolzenbach; D Fretland
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

2.  Effect of a 5-lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea-pig.

Authors:  M M Teixeira; P G Hellewell
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

3.  Involvement of leukotrienes in allergic pleurisy in actively sensitized rats: inhibition by the lipoxygenase inhibitor T-0757 of the increase in vascular permeability and leukotriene E4 production.

Authors:  M Kikuchi; K Tsuzurahara; T Suzuki; N Yato; K Naito
Journal:  Inflamm Res       Date:  1996-04       Impact factor: 4.575

4.  In vitro susceptibility of Helicobacter pylori to protolichesterinic acid from the lichen Cetraria islandica.

Authors:  K Ingolfsdottir; M A Hjalmarsdottir; A Sigurdsson; G A Gudjonsdottir; A Brynjolfsdottir; O Steingrimsson
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

5.  Effect of BW B70C, a novel inhibitor of arachidonic acid 5-lipoxygenase, on allergen-induced bronchoconstriction and late-phase lung eosinophil accumulation in sensitised guinea-pigs.

Authors:  M Yeadon; F L Dougan; A Petrovic; J E Beesley; A N Payne
Journal:  Agents Actions       Date:  1993-01

6.  Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.

Authors:  R M McMillan; K E Spruce; G C Crawley; E R Walker; S J Foster
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.